TY  - CHAP
M1  - Book, Section
TI  - ST-Elevation Myocardial Infarction
A1  - Ibanez, Borja
A1  - Patel, Manesh
A1  - García-Lunar, Inés
A1  - Baber, Usman
A1  - Halperin, Jonathan
A1  - Fuster, Valentin
A2  - Fuster, Valentin
A2  - Narula, Jagat
A2  - Vaishnava, Prashant
A2  - Leon, Martin B.
A2  - Callans, David J.
A2  - Rumsfeld, John S.
A2  - Poppas, Athena
PY  - 2022
T2  - Fuster and Hurst's The Heart, 15e
AB  - Content  UpdateAEGIS-II  Trial:  Apolipoprotein  A1  Infusions  and  Cardiovascular  Outcomes  after  Acute  Myocardial  InfarctionThis  phase  3  randomized,  placebo-controlled  trial  assessed  the  efficacy  and  safety  of  CSL112,  a  human  plasma-derived  apolipoprotein  A1  that  increases  cholesterol  efflux  capacity,  in  high-risk  patients  (multivessel  coronary  artery  disease,  and  pharmacologic  treatment  of  diabetes  or  two  additional  risk  factors:  age  65  years  or  older,  history  of  MI,  peripheral  artery  disease)  after  acute  myocardial  infarction  (MI).  Read  More  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/10/14
UR  - accesscardiology.mhmedical.com/content.aspx?aid=1207966652
ER  -